About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Neurological Biomarkers Market Size, Share and Forecast to 2031

Neurological Biomarkers Market

Neurological Biomarkers Market: Information by Type (Genomic, Proteomic), End-User (Hospitals and Hospital Laboratories, Research Organizations), and Regions—Forecast till 2031

The global neurological biomarkers market size was valued at USD 7,823.39 million in 2022. It is estimated to reach USD 23,332.71 million by 2031, growing at a CAGR of 12.91% during the forecast period (2023–2031). Neurological bioma
Report Code: SRHI54818DR
Buy Now
File Formats

Market Segmentation

  1. Neurological Biomarkers Market, By Type (2021-2031)
    1. Genomic
    2. Proteomic
    3. Metabolomic
    4. Imaging
    5. Others
  2. Neurological Biomarkers Market, By Applications (2021-2031)
    1. Alzheimer's Disease
    2. Parkinson’s Disease
    3. Multiple Sclerosis
    4. Autism Spectrum Disorders
    5. Others
  3. Neurological Biomarkers Market, By End-User (2021-2031)
    1. Hospitals and Hospital Laboratories
    2. Independent Clinical Diagnostic Centers
    3. Research Organizations and Other
    1. North America
      1. North America Neurological Biomarkers Market, By Type
        1. Genomic
          1. Proteomic
            1. Metabolomic
              1. Imaging
                1. Others
                2. North America Neurological Biomarkers Market, By Applications
                  1. Alzheimer's Disease
                    1. Parkinson’s Disease
                      1. Multiple Sclerosis
                        1. Autism Spectrum Disorders
                          1. Others
                          2. North America Neurological Biomarkers Market, By End-User
                            1. Hospitals and Hospital Laboratories
                              1. Independent Clinical Diagnostic Centers
                                1. Research Organizations and Other
                                2. U.S.
                                  1. U.S. Neurological Biomarkers Market, By Type
                                    1. Genomic
                                      1. Proteomic
                                        1. Metabolomic
                                          1. Imaging
                                            1. Others
                                            2. U.S. Neurological Biomarkers Market, By Applications
                                              1. Alzheimer's Disease
                                                1. Parkinson’s Disease
                                                  1. Multiple Sclerosis
                                                    1. Autism Spectrum Disorders
                                                      1. Others
                                                      2. U.S. Neurological Biomarkers Market, By End-User
                                                        1. Hospitals and Hospital Laboratories
                                                          1. Independent Clinical Diagnostic Centers
                                                            1. Research Organizations and Other
                                                          2. Canada
                                                        2. Europe
                                                          1. Europe Neurological Biomarkers Market, By Type
                                                            1. Genomic
                                                              1. Proteomic
                                                                1. Metabolomic
                                                                  1. Imaging
                                                                    1. Others
                                                                    2. Europe Neurological Biomarkers Market, By Applications
                                                                      1. Alzheimer's Disease
                                                                        1. Parkinson’s Disease
                                                                          1. Multiple Sclerosis
                                                                            1. Autism Spectrum Disorders
                                                                              1. Others
                                                                              2. Europe Neurological Biomarkers Market, By End-User
                                                                                1. Hospitals and Hospital Laboratories
                                                                                  1. Independent Clinical Diagnostic Centers
                                                                                    1. Research Organizations and Other
                                                                                    2. U.K.
                                                                                      1. U.K. Neurological Biomarkers Market, By Type
                                                                                        1. Genomic
                                                                                          1. Proteomic
                                                                                            1. Metabolomic
                                                                                              1. Imaging
                                                                                                1. Others
                                                                                                2. U.K. Neurological Biomarkers Market, By Applications
                                                                                                  1. Alzheimer's Disease
                                                                                                    1. Parkinson’s Disease
                                                                                                      1. Multiple Sclerosis
                                                                                                        1. Autism Spectrum Disorders
                                                                                                          1. Others
                                                                                                          2. U.K. Neurological Biomarkers Market, By End-User
                                                                                                            1. Hospitals and Hospital Laboratories
                                                                                                              1. Independent Clinical Diagnostic Centers
                                                                                                                1. Research Organizations and Other
                                                                                                              2. Germany
                                                                                                              3. France
                                                                                                              4. Spain
                                                                                                              5. Italy
                                                                                                              6. Russia
                                                                                                              7. Nordic
                                                                                                              8. Benelux
                                                                                                              9. Rest of Europe
                                                                                                            2. APAC
                                                                                                              1. APAC Neurological Biomarkers Market, By Type
                                                                                                                1. Genomic
                                                                                                                  1. Proteomic
                                                                                                                    1. Metabolomic
                                                                                                                      1. Imaging
                                                                                                                        1. Others
                                                                                                                        2. APAC Neurological Biomarkers Market, By Applications
                                                                                                                          1. Alzheimer's Disease
                                                                                                                            1. Parkinson’s Disease
                                                                                                                              1. Multiple Sclerosis
                                                                                                                                1. Autism Spectrum Disorders
                                                                                                                                  1. Others
                                                                                                                                  2. APAC Neurological Biomarkers Market, By End-User
                                                                                                                                    1. Hospitals and Hospital Laboratories
                                                                                                                                      1. Independent Clinical Diagnostic Centers
                                                                                                                                        1. Research Organizations and Other
                                                                                                                                        2. China
                                                                                                                                          1. China Neurological Biomarkers Market, By Type
                                                                                                                                            1. Genomic
                                                                                                                                              1. Proteomic
                                                                                                                                                1. Metabolomic
                                                                                                                                                  1. Imaging
                                                                                                                                                    1. Others
                                                                                                                                                    2. China Neurological Biomarkers Market, By Applications
                                                                                                                                                      1. Alzheimer's Disease
                                                                                                                                                        1. Parkinson’s Disease
                                                                                                                                                          1. Multiple Sclerosis
                                                                                                                                                            1. Autism Spectrum Disorders
                                                                                                                                                              1. Others
                                                                                                                                                              2. China Neurological Biomarkers Market, By End-User
                                                                                                                                                                1. Hospitals and Hospital Laboratories
                                                                                                                                                                  1. Independent Clinical Diagnostic Centers
                                                                                                                                                                    1. Research Organizations and Other
                                                                                                                                                                  2. Korea
                                                                                                                                                                  3. Japan
                                                                                                                                                                  4. India
                                                                                                                                                                  5. Australia
                                                                                                                                                                  6. Taiwan
                                                                                                                                                                  7. South East Asia
                                                                                                                                                                  8. Rest of Asia-Pacific
                                                                                                                                                                2. Middle East and Africa
                                                                                                                                                                  1. Middle East and Africa Neurological Biomarkers Market, By Type
                                                                                                                                                                    1. Genomic
                                                                                                                                                                      1. Proteomic
                                                                                                                                                                        1. Metabolomic
                                                                                                                                                                          1. Imaging
                                                                                                                                                                            1. Others
                                                                                                                                                                            2. Middle East and Africa Neurological Biomarkers Market, By Applications
                                                                                                                                                                              1. Alzheimer's Disease
                                                                                                                                                                                1. Parkinson’s Disease
                                                                                                                                                                                  1. Multiple Sclerosis
                                                                                                                                                                                    1. Autism Spectrum Disorders
                                                                                                                                                                                      1. Others
                                                                                                                                                                                      2. Middle East and Africa Neurological Biomarkers Market, By End-User
                                                                                                                                                                                        1. Hospitals and Hospital Laboratories
                                                                                                                                                                                          1. Independent Clinical Diagnostic Centers
                                                                                                                                                                                            1. Research Organizations and Other
                                                                                                                                                                                            2. UAE
                                                                                                                                                                                              1. UAE Neurological Biomarkers Market, By Type
                                                                                                                                                                                                1. Genomic
                                                                                                                                                                                                  1. Proteomic
                                                                                                                                                                                                    1. Metabolomic
                                                                                                                                                                                                      1. Imaging
                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                        2. UAE Neurological Biomarkers Market, By Applications
                                                                                                                                                                                                          1. Alzheimer's Disease
                                                                                                                                                                                                            1. Parkinson’s Disease
                                                                                                                                                                                                              1. Multiple Sclerosis
                                                                                                                                                                                                                1. Autism Spectrum Disorders
                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                  2. UAE Neurological Biomarkers Market, By End-User
                                                                                                                                                                                                                    1. Hospitals and Hospital Laboratories
                                                                                                                                                                                                                      1. Independent Clinical Diagnostic Centers
                                                                                                                                                                                                                        1. Research Organizations and Other
                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                      1. LATAM Neurological Biomarkers Market, By Type
                                                                                                                                                                                                                        1. Genomic
                                                                                                                                                                                                                          1. Proteomic
                                                                                                                                                                                                                            1. Metabolomic
                                                                                                                                                                                                                              1. Imaging
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                2. LATAM Neurological Biomarkers Market, By Applications
                                                                                                                                                                                                                                  1. Alzheimer's Disease
                                                                                                                                                                                                                                    1. Parkinson’s Disease
                                                                                                                                                                                                                                      1. Multiple Sclerosis
                                                                                                                                                                                                                                        1. Autism Spectrum Disorders
                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                          2. LATAM Neurological Biomarkers Market, By End-User
                                                                                                                                                                                                                                            1. Hospitals and Hospital Laboratories
                                                                                                                                                                                                                                              1. Independent Clinical Diagnostic Centers
                                                                                                                                                                                                                                                1. Research Organizations and Other
                                                                                                                                                                                                                                                2. Brazil
                                                                                                                                                                                                                                                  1. Brazil Neurological Biomarkers Market, By Type
                                                                                                                                                                                                                                                    1. Genomic
                                                                                                                                                                                                                                                      1. Proteomic
                                                                                                                                                                                                                                                        1. Metabolomic
                                                                                                                                                                                                                                                          1. Imaging
                                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                                            2. Brazil Neurological Biomarkers Market, By Applications
                                                                                                                                                                                                                                                              1. Alzheimer's Disease
                                                                                                                                                                                                                                                                1. Parkinson’s Disease
                                                                                                                                                                                                                                                                  1. Multiple Sclerosis
                                                                                                                                                                                                                                                                    1. Autism Spectrum Disorders
                                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                                      2. Brazil Neurological Biomarkers Market, By End-User
                                                                                                                                                                                                                                                                        1. Hospitals and Hospital Laboratories
                                                                                                                                                                                                                                                                          1. Independent Clinical Diagnostic Centers
                                                                                                                                                                                                                                                                            1. Research Organizations and Other
                                                                                                                                                                                                                                                                          2. Mexico
                                                                                                                                                                                                                                                                          3. Argentina
                                                                                                                                                                                                                                                                          4. Chile
                                                                                                                                                                                                                                                                          5. Colombia
                                                                                                                                                                                                                                                                          6. Rest of LATAM

                                                                                                                                                                                                                                                                      Related Reports

                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      The global digital biomarkers market size was valued at USD 1.8 billion in 2021. It is projected to reach USD 27.17 billion by 2030, growing at a CAGR of 35.20% during the forecast period (2022–2030). Digital Biomarkers are the data used to tr
                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      The global renal biomarkers market size was valued at USD 1,119.82 million in 2022. It is estimated to reach USD 2,158.11 million by 2031, growing at a CAGR of 7.56% during the forecast period (2023–2031). Biomarkers are substances that c
                                                                                                                                                                                                                                                                      Buy Now

                                                                                                                                                                                                                                                                      Purchase Benefits

                                                                                                                                                                                                                                                                      • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                      • Completely customizable scope
                                                                                                                                                                                                                                                                      • 30% discount on your next purchase
                                                                                                                                                                                                                                                                      • Dedicated account manager
                                                                                                                                                                                                                                                                      • Query resolution within 24 hours
                                                                                                                                                                                                                                                                      • Permission to print the report

                                                                                                                                                                                                                                                                      We are featured on :

                                                                                                                                                                                                                                                                      www.straitsresearch.com
                                                                                                                                                                                                                                                                      © Copyright . All rights Reserved.